Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

Is that better greekman. Let's hope it can be sustained.
2517

Now why can't the UK Health Authorities make the obvious money + life saving no brainer decisions like the Spanish
Use of CardioQ-ODM to guide intravascular fluids is now one of four 'mandatory' steps. This means that any of the new hospitals looking to join the project, as well as current participants, must use the CardioQ-ODM on 100% of colorectal patients treated within the enhanced recovery programme.

What a nice ring that word 'mandatory' has to it.

Placing.....Good news or Bad.

As for the placing instead of going for a rights issue, usually I feel aggrieved when existing shareholders are not given a chance to be included, BUT in this instance I am wondering if the far quicker way of raising cash is due to the requirement of such cash soonest. After all on 3 September 2009 the Company announced its unaudited interim results for the six months ended 30 June 2009. In that announcement it was reported that in the UK sales of the Company's operating theatre probes had increased by 17 per cent. and, other than the record probe sales achieved in December 2008, Deltex Medical delivered its best ever months for probe sales in each of April, June and July during the current financial year. In its most developed region in the USA the Company increased both probe volumes and revenues by over 50 per cent. Sales to distributors in Europe increased by over 40 per cent.

I just hope that there is a biggish contract in the very near offing.
The market seems to like it. Wonder what they know that we don't, as placings usually without some specific statement usually don't have this much positive effect on the sp.

Regards Greek

Looks like I was right for a change re something in the offing. OK not yet a contract but todays RNS is I feel the match that will ignite Deltex's share price. I feel that this latest news will launch the company on the road to profitability.
We have had so many false dawns (not really the companies fault) just procrastination on the part of Health Authorities.
Surely we have now reached the point of confidence overruling negativity.

Am I right or wrong.

Part of todays news release states.....The study, on critically ill patients in intensive care, noted unacceptably large percentage errors in the PPWA device relative to ODM and poor correlation after haemodynamic change. It noted that most validation studies of PPWA approaches had been performed in select groups of surgical patients and that few of these had assessed PPWA's ability to track change.

The study concluded that: the PPWA device "showed poor agreement" with ODM as the reference technique.

Lidco is often mentioned as a rival to Deltex. As I understand it apart from their product being slightly more evasive than the Deltex product, am I correct in believing that the Lidco system is the PPWA system that is mentioned above. If not it looks o have far more similarities to the PPWA system than the ODM.
Usually don't like to ask questions when I can find the answers myself, but have spent over an hour trying to confirm or not to no avail.

greekman the outlook seems to be improving albeit slowly. You are correct see post 659 and the shares mag for 3/9/09 (which I have unfortunately binned). As for the placing I also think the requirement for quick cash was the important factor, and @ 2.7% discount who can complain.
2517

George,

Many thanks your reply. As your post of 659 has confirmed my query re Lidco and their PPWA system (or as need as dam it) I think that the latest from Deltex could/should mean that they now start to pull way ahead. If I held shares in Lidco I would be very worried indeed.

regards Greek.

One day our faith in DEMG may be handsomely rewarded.
2517

Ah, Faith (I'm an atheist) patience I have very little. But yes one day.

Strange. Up to 1043 hrs shares on the AIM were almost parallelling with those on Plus. Since 1043 hrs there have been no trades on AIM and yet a continuation on Plus of about the same consistency.
What say they are (for whatever reason) not releasing trades on AIM and saving them for later release as they sometimes do when a large deal is forthcoming.
I don't believe there have been no trades since 1043 hrs on one market when the trading pattern has continued on another.

Placing or not, its nice to see a new player take a stake of over 9% of the company. Slight discount or not, it shows faith in the product and the company.

Gartmore have taken 420,000 more. Not much of an increase in their holdings, but an increase all the same. What I and no doubt all of us are waiting for are increases of several million, that will no doubt precede some explosive news. Something to really move this share.

Nice to see 2 bits of news on the same day. When the news flow increases as now, it 'MUST' surely convert into an increased sp. I can't see how orders won't follow.

And the first trade semi decent of the day is a sell. Says it all doesn't it.

My take on things.

I think that the Deltex sp is in a bit of a quagmire position. Due to its almost stagnation it appears that when good news is released and the sp ticks up a tad, punters are so used to it then sliding back down, instead of jumping in on the back of this news they instead think, 'It's ticked up, so I will take this as an opportunity to sell'. Whilst I appreciate when shares tick up this will always happen, in the case of Deltex it does appear disproportionate.
But because of this when/if it really does start to motor, many I feel will have got off the train just as it gains speed and is about to leave the station.

Re the Hanover connection. This could be one of Deltex's most important moves for many months.


Not an expert re Media or/and PR, but as they appear to have difficulty in putting their case over to those that hold the purse strings, it may be that companies such as Hanover can achieve for Deltex what their sales/media personnel can't achieve for themselves.
It might just be the time for Deltex to look for and receive help re sales, even if it costs.
Perhaps Hanover can rattle more cages than Deltex can. I have often thought that more media items, such as 'NHS trusts refuse to spend to save' would perhaps focus minds. With Hanover requesting info via re The Freedom Of Information act, the first cage could be about to rattle.
All IMHO of course.

http://www.hanovercomms.com/what-we-do/healthcare/

OK. Share options instead of cash nearly always a good idea, but this is getting a bit too often. Holdings diluted again. Hope we see these options earned soon, and not by just a trickle of sales.

But this shows not just commitment but real confidence, to buy at full price.

Nigel Keen 24,999.74 217,389 @ 11.50p
Edwin Snape 18,000.03 156,522 @ 11.50p
Duncan Nichol 14,399.96 Duncan K Nichol 125,217 @ 11.50p
Charles Cazalet 13,708.69 119,206 @ 11.50p

Greekman, providing the number of shares awarded was fair remuneration, then I read it as a positive sign. I have a feeling in my Oesophageal Doppler that 2010 will be the year that DEMG and it's sp make real progress. Good luck and A Happy New Year to All.
2517

Hi 2517George,

I totally agree re the 'Fair Remuneration'. Personally I would like to see any bonus/rise in remuneration tied to performance of the sp, or at least to performance of sales.
Yes, the sp can obviously go down therefore knocking the value of any taken up options, but they would still be in pocket unless they really bombed out.

To me 2010 has to be make or break year for Deltex.

By this time next year, we will either be sitting on a very nice gain, or thinking, yet another year without movement.
I do think the odds are they will make it, and make it big, although I also feel it will be a close run thing.

Wishing all a prosperous (I hope you all make money, but I hope I make more than you) and Happy New Year.

Pre close up-date looking fairly good.

Sales are growing in all our key markets and we are on track to achieve cash neutrality assuming continuing sales growth. The margin on sales in the second half of 2009 was approximately equivalent to our planned cash cost base in the first half of 2010.
Record probe sales in all key markets in the final quarter of the year indicate a return toward the strong growth trends established prior to the global financial crisis. The directors expect sales for 2009 to have been in excess of 5.6 million.

Last years full sales were 5,235,000 increased by 26% on the 2007 figure (2007: 4,168,000)

So although not much of an increase, it isn't bad considering the financial climate.
Also with the profit margin equivalent against the first 6 months of 2010 cost base things are looking up.

As said previously, I think 2010 will be make or break year.